筛选条件 共查询到78条结果
排序方式
Targeting the TGF-beta signaling pathway for fibrosis therapy: a patent review (2015-2020)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2021; 31 (8)

Introduction Fibrosis is a serious disease that occurs in many organs, such as kidney, liver and lung. The deterioration of these organs ultimately le......

An updated patent review of Akt inhibitors (2016-present)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2021; 31 (9)

Introduction: Akt is a widely known serine threonine kinase involved in a series of critical cellular pathways like cell survival and proliferation. W......

Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010-present)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2021; 31 (5)

Introduction: DNA-dependent protein kinase (DNA-PK) plays a crucial role in the repair of DSBs via non-homologous end joining (NHEJ). Several DNA-PK i......

Aurora kinase inhibitors: a patent review (2014-2020)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2021; 31 (7)

Introduction: Aurora kinases are a family of serine/threonine kinases, and promote mitotic spindle assembly by regulating centrosome duplication and s......

GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2021; 31 (9)

Introduction: Type 2 diabetes is a rapid-growing complex chronic metabolic disease characterized by hyperglycemia due to lessened insulin secretion, i......

Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, ; ()

Introduction Stimulator of interferon genes (STING) is a transmembrane protein that localizes in the endoplasmic reticulum. As a crucial adaptor prote......

An updated patent review of autotaxin inhibitors (2017-present)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, ; ()

Introduction: The ATX-LPA axis is an attractive target for therapeutic intervention in a variety of diseases, such as tumor metastasis, fibrosis, prur......

Discovery and optimizing polycyclic pyridone compounds as anti-HBV agents

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2020; 30 (9)

Introduction Hepatitis B disease is caused by the hepatitis B virus (HBV), which is a DNA virus that belongs to the Hepadnaviridae family. It is a con......

Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2020; 30 (9)

Introduction Therapeutic antibodies blocking co-inhibitory pathways do not attack tumor cells directly, but instead bind to their targeted proteins an......

Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2020; 30 (4)

Introduction: Histone deacetylase (HDAC) inhibitors play a crucial role in restoring the balance of acetylation and deacetylation of lysine residues o......

A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2020; 30 (5)

Introduction: Discoidin domain receptor 1 (DDR1) is a collagen-activated receptor tyrosine kinase. Upon collagen binding, DDR1 undergoes tyrosine auto......

PI3K delta inhibitors for the treatment of cancer: a patent review (2015-present)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2019; 29 (12)

Introduction: PI3K delta is an important subtype of PI3K kinases, which is mainly expressed in leukocytes and plays an important role in the prolifera......

JIF:3.7

c-Met kinase inhibitors: an update patent review (2014-2017)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2019; 29 (1)

Introduction: The receptor tyrosine kinase c-Met is involved in the formation, metastasis and invasion of various malignant tumors thus it has been an......

JIF:3.7

Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018)

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2019; 29 (2)

Introduction: Tyrosine kinase 2 (Tyk2) is a non-receptor tyrosine-protein kinase, an enzyme that in humans is encoded by the TYK2 gene. Tyk2, together......

JIF:3.7

Research and development of anti-Parkinson's drugs: an analysis from the perspective of technology flows measured by patent citations

期刊: EXPERT OPINION ON THERAPEUTIC PATENTS, 2019; 29 (2)

Introduction: By 2020, nearly one million people will live with Parkinson's disease (PD) in the U.S. This disorder has a significant impact on patient......

JIF:3.7

共78条页码: 1/6页15条/页